Capitalizing on measles vaccine’s successful history to protect against SARS-CoV-2

COLUMBUS, Ohio – A new SARS-CoV-2 vaccine candidate, developed by giving a key protein’s gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies. Scientists attribute the vaccine candidate’s effectiveness to strategic production…

FDA qualifies C-Path’s Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C)

TUCSON, Ariz., March 9, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces the qualification of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) by the U.S. Food and Drug Administration (FDA). The DIBSS-C was developed by the PRO Consortium’s Irritable Bowel Syndrome (IBS) Working Group to support symptom-based efficacy endpoints in clinical…

Re-envisioning the nursing PhD degree

PHILADELPHIA (March 9, 20201) – The PhD degree prepares nurse scientists to advance knowledge through research that improves health, translates into policy, and enhances education. However, as the role of the nurse has changed, and health care has grown more complex, there is a need to re-envision how PhD programs can attract, retain, and create…